Publications by authors named "Mike Sampson"

Claim this Profile
Q
Quantity and specificity of action-plans as predictors of weight loss: analysis of data from the Norfolk Diabetes Prevention Study (NDPS).
Nikki J Garner, Jane R Smith, Mike J Sampson, Colin J Greaves,

Psychol Health· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intervention fidelity assessment: A sub-study of the Norfolk Diabetes Prevention Study (NDPS).
Thomas M Withers, Nikki J Garner, Chris S Thorley, Jo Kellett, Lucy Price, Mike J Sampson

Br J Health Psychol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trained Volunteers With Type 2 Diabetes Experience Significant Health Benefits When Providing Peer Support.
Nikki J Garner, Martin Pond, Sara Auckland, Mike Sampson

Health Educ Behav· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT.
Simon J Griffin, M Angelyn Bethel, Rury R Holman, Kamlesh Khunti, Nicholas Wareham, Mike Sampson

Health Technol Assess· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance in glycemic categories and regression to normality at baseline in 10,000 people in a Type 2 diabetes prevention trial.
Mike Sampson, Tim Elwell-Sutton, Max O Bachmann, Allan Clark, Ketan K Dhatariya

Sci Rep· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study Protocol: The Norfolk Diabetes Prevention Study [NDPS]: a 46 month multi - centre, randomised, controlled parallel group trial of a lifestyle intervention [with or without additional support from lay lifestyle mentors with Type 2 diabetes] to prevent transition to Type 2 diabetes in high risk groups with non - diabetic hyperglycaemia, or impaired fasting glucose.
Melanie Pascale, Nikki Murray, Max Bachmann, Garry Barton, Allan Clark, Mike Sampson

BMC Public Health· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Draznin et al. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care 2013;36:1807-1814.
Ketan Dhatariya, Mike Sampson, Chris Walton, Gerry Rayman, Esther Walden

Diabetes Care· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: a double-blind randomized controlled trial.
Peter J Curtis, John Potter, Paul A Kroon, Paddy Wilson, Ketan Dhatariya, Mike Sampson

Am J Clin Nutr· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A motivational peer support program for type 2 diabetes prevention delivered by people with type 2 diabetes: the UEA-IFG feasibility study.
Nikki J Murray, Amy V Gasper, Lisa Irvine, Tracey J Scarpello, Mike J Sampson

Diabetes Educ· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial.
Peter J Curtis, Mike Sampson, John Potter, Ketan Dhatariya, Paul A Kroon

Diabetes Care· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of a lifestyle intervention in preventing Type 2 diabetes.
Lisa Irvine, Garry R Barton, Amy V Gasper, Nikki Murray, Allan Clark, Mike Sampson

Int J Technol Assess Health Care· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes.
John R B Perry, Michael N Weedon, Claudia Langenberg, Anne U Jackson, Valeriya Lyssenko, Mike Sampson

Hum Mol Genet· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of association of colonic epithelium telomere length and oxidative DNA damage in Type 2 diabetes under good metabolic control.
Deepak Kejariwal, Karolina M Stepien, Tracy Smith, Hugh Kennedy, David A Hughes, Mike J Sampson

BMC Endocr Disord· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low density lipoprotein from patients with Type 2 diabetes increases expression of monocyte matrix metalloproteinase and ADAM metalloproteinase genes.
Joanna R Worley, David A Hughes, Nicoletta Dozio, Jelena Gavrilovic, Mike J Sampson

Cardiovasc Diabetol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total and excess bed occupancy by age, specialty and insulin use for nearly one million diabetes patients discharged from all English Acute Hospitals.
Mike J Sampson, Nicoletta Dozio, Brian Ferguson, Ketan Dhatariya

Diabetes Res Clin Pract· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pro-oxidant effect of alpha-tocopherol in patients with type 2 diabetes after an oral glucose tolerance test--a randomised controlled trial.
Mark S Winterbone, Mike J Sampson, Shikha Saha, Jackie C Hughes, David A Hughes

Cardiovasc Diabetol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes.
Mike J Sampson, Mark S Winterbone, Jackie C Hughes, Nicoletta Dozio, David A Hughes

Diabetes Care· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monocyte matrix and ADAM metalloproteinase expression in type 2 diabetes after aspirin therapy.
Mike Sampson, Steven Wall, Mark Baugh, Jo Worley, Isabel Davies

Diabetes Res Clin Pract· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.
Mike J Sampson, Simon Braschi, Gavin Willis, Sian B Astley

Clin Sci (Lond)· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association studies of insulin receptor substrate 1 gene (IRS1) variants in type 2 diabetes samples enriched for family history and early age of onset.
Eleftheria Zeggini, James Parkinson, Stephanie Halford, Katharine R Owen, Timothy M Frayling, Mike J Sampson

Diabetes· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type 2 diabetes.
Mike Sampson, Isabel Davies, Jelena Gavrilovic, Brendan Sussams, Jackie Brown

Cardiovasc Diabetol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence from a large U.K. family collection that genes influencing age of onset of type 2 diabetes map to chromosome 12p and to the MODY3/NIDDM2 locus on 12q24.
Steven Wiltshire, Timothy M Frayling, Christopher J Groves, Jonathan C Levy, Graham A Hitman, Mike Sampson

Diabetes· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metalloproteinase expression in PMA-stimulated THP-1 cells. Effects of peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists and 9-cis-retinoic acid.
Joanna R Worley, Mark D Baugh, David A Hughes, Dylan R Edwards, Aileen Hogan, Mike J Sampson

J Biol Chem· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility.
Michael N Weedon, Peter E H Schwarz, Yukio Horikawa, Naoko Iwasaki, Thomas Illig, Mike Sampson

Am J Hum Genet· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Young-onset type 2 diabetes families are the major contributors to genetic loci in the Diabetes UK Warren 2 genome scan and identify putative novel loci on chromosomes 8q21, 21q22, and 22q11.
Timothy M Frayling, Steven Wiltshire, Graham A Hitman, Mark Walker, Jonathan C Levy, Mike Sampson

Diabetes· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis